Skip to main content

Access to Pharmaceuticals

Objective

Access to Pharmaceuticals Equitable access to pharmaceuticals, particularly for developing countries is an essential human right. Various complex impediments hinder access, which is the subject of ongoing multidisciplinary studies. Intellectual Property and product development are two issues that can be used as tools to address the problem of access, particularly to make patented drugs more affordable and accessible. This proposal addresses three ways of accomplishing this. The first is how academic licensing practices under socially responsible stewardship can ensure that future drugs that have resulted from inventive activity in academia will be available at low cost with improved access in the future. Secondly we will research thoroughly how existing public-private or product-development partnerships are addressing the issue of altruistic development of drugs for relatively neglected populations with unmet health needs and the lessons they have for future drug development. Lastly it addresses the current state and future improvements in compulsory licensing legislative instruments to enable access through generic manufacture of patented drugs. The three routes to access have several significant aspects of overlap which provide for complementary approaches and solutions to access.

Call for proposal

FP7-HEALTH-2009-single-stage
See other projects for this call

Funding Scheme

CP-FP-SICA - Small/medium-scale focused research project for specific cooperation actions dedicated to international cooperation partner countries(SICA)

Coordinator

ST GEORGE'S HOSPITAL MEDICAL SCHOOL
Address
Cranmer Terrace
SW17 0RE London
United Kingdom
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 469 942,40
Administrative Contact
Paul Craven (Dr.)

Participants (4)

UNIVERSITE DE NEUCHATEL
Switzerland
EU contribution
€ 404 299,60
Address
Faubourg De L'hopital 41
2000 Neuchatel
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Daniel Kraus (Dr.)
SOUTH AFRICAN MEDICAL RESEARCH COUNCIL
South Africa
EU contribution
€ 366 532
Address
Francie Van Zijl Drive - Parowvalley
7505 Tygerberg
Activity type
Research Organisations
Administrative Contact
Philip Du Plessis (Mr.)
INTERNATIONAL VACCINE INSTITUTE
South Korea
EU contribution
€ 160 000
Address
San 4-8 Bongcheon-7 Dong, Kwanak Gu
151919 Seoul
Activity type
Research Organisations
Administrative Contact
Richard Mahoney (Dr.)
FUNDACAO OSWALDO CRUZ
Brazil
EU contribution
€ 354 000
Address
Avenida Brasil 4365
21040 900 Rio De Janeiro
Activity type
Research Organisations
Administrative Contact
Carlos Medicis Morel (Prof.)